Pituitary tumorsPrognostic indicators

被引:18
作者
Wolfgang Saeger
机构
[1] University of Hamburg,Institute of Pathology of the Marienkrankenhaus Hamburg
关键词
Inactive adenoma; pituitary; tumor; adenoma; atypical adenoma; carcinoma;
D O I
10.1385/ENDO:28:1:057
中图分类号
学科分类号
摘要
Many factors influence the proliferation of pituitary adenomas: angiogenesis, apoptosis, growth factors, oncogenes, tumor suppressor genes, and hormone receptors. These elements can be demonstrated by immunohistochemistry and/or molecular pathology but no single factor can be used for determination of biological behavior resp. prognosis. Pituitary adenomas can be enclosed or invasive and may be very large or may be microadenomas, but the most important point for prognosis is the total resection in the first or second surgery or the reaction on treatments by drugs. Especially for residual tumor tissue proliferation, markers are important because they may indicate the growth rate and the aggressiveness of the tumor. Radiation therapy is indicated in many of these recurrent tumors and can improve the prognosis.
引用
收藏
页码:57 / 66
页数:9
相关论文
共 50 条
  • [41] PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines
    Minematsu, Takeo
    Egashira, Noboru
    Kajiya, Hanako
    Takei, Mao
    Takekoshi, Susumu
    Itoh, Yoshiko
    Tsukamoto, Hideo
    Itoh, Johbu
    Sanno, Naoko
    Teramoto, Akira
    Osamura, Robert Yoshiyuki
    ENDOCRINE PATHOLOGY, 2007, 18 (01) : 8 - 15
  • [42] Immunohistochemical Expression of p16 and p21 in Pituitary Tissue Adjacent to Pituitary Adenoma versus Pituitary Tissue Obtained at Autopsy: Is There a Difference?
    Gacic, Emilija Manojlovic
    Skender-Gazibara, Milica
    Soldatovic, Ivan
    Dundjerovic, Dusko
    Boricic, Novica
    Raicevic, Savo
    Popovic, Vera
    ENDOCRINE PATHOLOGY, 2015, 26 (02) : 104 - 110
  • [43] What to do with a pituitary incidentaloma?
    Beckers, Albert
    Daly, Adrian F.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (04) : 505 - 507
  • [44] Dural enhancement in pituitary macroadenomas
    F. Cattin
    F. Bonneville
    I. Andréa
    E. Barrali
    J. F. Bonneville
    Neuroradiology, 2000, 42 : 505 - 508
  • [45] Stereotactic radiosurgery for pituitary metastases
    Kano, Hideyuki
    Niranjan, Ajay
    Kondziolka, Douglas
    Flickinger, John C.
    Lunsford, L. Dade
    SURGICAL NEUROLOGY, 2009, 72 (03): : 248 - 255
  • [46] Pathology of the human pituitary adenomas
    Robert Y. Osamura
    Hanako Kajiya
    Mao Takei
    Noboru Egashira
    Maya Tobita
    Susumu Takekoshi
    Akira Teramoto
    Histochemistry and Cell Biology, 2008, 130
  • [47] MRI of pituitary hyperplasia in hypothyroidism
    Wolansky, LJ
    Leavitt, GD
    Elias, BJ
    Lee, HJ
    Dasmahapatra, A
    Byrne, W
    NEURORADIOLOGY, 1996, 38 (01) : 50 - 52
  • [48] Akting and cycling: A tale of the pituitary
    Grossman, AB
    Korbonits, M
    HORMONE RESEARCH, 2004, 62 : 117 - 123
  • [49] Dural enhancement in pituitary macroadenomas
    Cattin, F
    Bonneville, F
    Andréa, I
    Barrali, E
    Bonneville, JF
    NEURORADIOLOGY, 2000, 42 (07) : 505 - 508
  • [50] Mortality following pituitary radiotherapy
    Ayuk, John
    Stewart, Paul M.
    PITUITARY, 2009, 12 (01) : 35 - 39